Mirae Asset Global Investments Co. Ltd. Has $6.51 Million Stake in CVS Health Co. (NYSE:CVS)

Mirae Asset Global Investments Co. Ltd. lessened its position in CVS Health Co. (NYSE:CVS) by 7.6% in the third quarter, HoldingsChannel.com reports. The fund owned 106,056 shares of the pharmacy operator’s stock after selling 8,763 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in CVS Health were worth $6,510,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the third quarter valued at approximately $31,000. First Community Trust NA boosted its position in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the period. Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the third quarter valued at $33,000. ORG Partners LLC raised its position in shares of CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the period. Finally, Oliver Lagore Vanvalin Investment Group boosted its holdings in shares of CVS Health by 71.0% during the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 247 shares during the period. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on CVS. Deutsche Bank Aktiengesellschaft lowered their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Truist Financial upped their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a report on Friday, October 11th. Barclays dropped their target price on CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday, October 23rd. Finally, TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $74.58.

CVS Health Stock Up 1.5 %

NYSE CVS opened at $57.36 on Tuesday. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The business has a fifty day moving average price of $59.79 and a two-hundred day moving average price of $59.76. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock has a market capitalization of $72.01 billion, a PE ratio of 10.08, a PEG ratio of 0.84 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue was up 2.6% compared to the same quarter last year. During the same period last year, the firm posted $2.21 earnings per share. Equities analysts expect that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.64%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.